https://www.selleckchem.com/products/pt2399.html
High CHA DS -VASC and HAS-BLED scores are linked to increased mortality in structural and nonstructural cardiovascular interventions irrespective of the presence of atrial fibrillation (AF) or oral anticoagulation. We aimed to use the aforementioned scores to quantify the risk of 30-day mortality, major vascular and bleeding events (MVASC/BARC), and cerebrovascular insults (CVI) in patients undergoing different access routes in transcatheter aortic valve replacement (TAVR). Out of 1329 patients, 980 transfemoral (TF) TAVR (73.7%) and 349
Like
Comment
Share
